ZC3H12C and colorectal cancer: Reduced expression of ZC3H12C may disrupt the regulation of inflammatory responses and immune tolerance in the tumor microenvironment, thereby facilitating colorectal cancer progression through enhanced immune evasion and tumor cell survival (15).